Connect with us

Published

on

Philip O’Keefe, one of Synchron’s patients in the SWITCH clinical trial, was the first person in the world to tweet using a BCI device.

Source: Synchron

Neurotech startup Synchron is ramping up production of its flagship brain-computer interface to prepare for commercial demand, as the company inches closer to bringing its device to market. 

Synchron announced Thursday that it has acquired a minority equity stake in the German manufacturer Acquandas, which has the unique ability to layer the metals that make up one component of the company’s implant. 

As part of the deal, Synchron will get exclusive access to Acquandas’ layering technology for medical devices, and Synchron’s CEO Tom Oxley and CTO Riki Banerjee will join the manufacturer’s board.

Founded in 2012, Synchron has developed a brain-computer interface, or a BCI, called the Synchron Switch. The stent-like device is inserted through the patient’s blood vessels, and it allows people with limited physical mobility to operate technology like smart home devices and cursors with their mind.

During initial studies, Synchron has so far implanted six patients in the U.S. and four patients in Australia. The company will have to carry out additional trials that demonstrate the safety and efficacy of its device before regulators in the U.S. Food and Drug Administration grant approval for broader commercialization. 

Oxley said Synchron has worked with Acquandas for years, but the official partnership will help the company continue to innovate around implantable neurotechnology and scale to address a “very large unmet need.”  

“There are millions of people with paralysis who we think are in need of this technology, and we’re preparing to produce in high volumes,” Oxley told CNBC in an interview. 

Synchron declined to share the specific size of Synchron’s stake in Acquandas or the exact number of devices it is producing.

A close up of Synchron’s device.

Courtesy: Synchron

As the company is working to ramp up its manufacturing, it is also hoping to gauge interest from more prospective patients. Synchron is planning to launch an official patient registry in mid-February that will allow patients with limb or motor impairment to stay updated about trials and share details about their needs. 

“We wanted to create a mechanism where people could express interest, and it’s going to help us shape the consideration for which clinical sites across the US we focus in first,” Oxley said.

Although Synchron still has a long road ahead, the company has already caught the attention of powerful investors and competitors.  

In 2022, Synchron announced a $75 million financing round that included funding from the investment firms of both Microsoft co-founder Bill Gates and Amazon founder Jeff Bezos. Tesla and SpaceX CEO Elon Musk, who owns the BCI company Neuralink, asked a number of questions about Synchron during a meeting with Neuralink executives and engineers in July 2022, according to a report from Bloomberg

Like many other BCI companies, Neuralink’s system is designed to be implanted directly into a patient’s brain tissue through open brain surgery. By inserting a BCI directly into the tissue, the quality of the neural signals should be strong, but the nature of the procedure makes it inherently riskier.  

Musk announced that Neuralink implanted its device in a human for the first time on Sunday, and that the patient is “recovering well,” according to a post on X.

Synchron relies on a less-invasive approach for implanting its BCI that builds on existing endovascular techniques. The company’s stent, called the Stentrode, is fitted with tiny sensors and, after insertion, is delivered to the large vein that sits next to the motor cortex. 

Since Synchron’s BCI isn’t inserted directly into the brain tissue, the quality of the brain signals is not as strong, according to the company. But the team believes the minimally invasive nature of the procedure will ultimately make it more accessible. 

“We should be far exceeding the Stentrode,” Musk said at Neuralink’s July meeting, according to Bloomberg. “And they are currently kicking our a**.”

Continue Reading

Technology

Trump’s latest chip tariff announcement raises more questions than answers

Published

on

By

Trump's latest chip tariff announcement raises more questions than answers

U.S. President Donald Trump speaks to reporters near Air Force One at the the Lehigh Valley International Airport on August 03, 2025 in Allentown, Pennsylvania.

Anna Moneymaker | Getty Images

After months of speculation, U.S. President Donald Trump has divulged more of his semiconductor tariff plans, but his latest threats might raise more questions than answers. 

On Wednesday, Trump said he will impose a 100% tariff on imports of semiconductors and chips, but not for companies that are “building in the United States.”

As semiconductors represent an over $600 billion industry at the heart of the modern digital economy, any potential tariffs hold massive weight. 

However, experts say the President has yet to provide key details on the policy, which will ultimately determine their full impact and targets. 

“It’s still too early to pin down the impact of the tariffs on the semiconductor sector,”  Ray Wang, research director of semiconductors, supply chain and emerging technology at The Futurum Group, told CNBC. 

“The final rule is likely still being drafted and the technical details are far from clear at this point.” 

Big players win?

One of the biggest questions for chip players and investors will be how much manufacturing a company needs to commit to the U.S. to qualify for the tariff exemption. 

The U.S. has been working to onshore its semiconductor supply chain for many years now. Since 2020, the world’s largest semiconductor companies such as TSMC and Samsung Electronics have committed hundreds of billions of dollars to building plants in the U.S.

Speaking to CNBC’s “Squawk Box Asia” on Thursday, James Sullivan, Managing Director and Head of Asia Pacific Equity Research at J.P. Morgan, said this could mean most major chip manufacturers receiving exemptions.

If this is the case, the policy could have the effect of “continuing to consolidate market share amongst the largest cap players in the space,” Sullivan said. 

Indeed, shares of major Asian chip companies like TSMC, which has significant investments in the U.S., rose in Thursday morning trading following Trump’s announcement. Early this year, TSMC announced it would expand its investments in the U.S. to $165 billion. 

Shares of South Korea’s Samsung and SK Hynix — which have also invested in the U.S. — were also trading up after a Korean trade envoy reportedly said on radio that the duo would be exempt from the 100% tariffs.

An exemption on what? 

Beyond the question of exemptions, many other aspects of the potential tariffs remain unclear. 

Speaking on CNBC’s “Squawk Box Asia,” on Thursday, Stacy Rasgon, senior U.S. semiconductor analyst at  Bernstein, noted that most of the semiconductors that enter the U.S. come inside consumer goods such as smartphones, PCs and cars.

For example, in 2024, the U.S. imported $46.3 billion of semiconductors — only about 1% of all U.S. imports, according to the Information Technology and Innovation Foundation.

While Rasgon said tariffs on these imports may be manageable, broader tariffs would be harder to deal with. 

“What we don’t know with [Trump’s] comments on tariffs, is it just raw semiconductors? Are there going to be tariffs on end devices? Are you going to be looking at tariffs on components within end devices?,” Rasgon asked. 

The confusion and questions around semiconductor tariffs were brought to the forefront after the U.S. Department of Commerce started a national security investigation of semiconductor imports in April, just as the sector was exempted from Trump’s “reciprocal” tariffs.

The vague language from the Trump administration — though not invoked in the president’s latest proclamations — could theoretically be used to apply broad tariffs to an enormous segment of the electronics supply chain. It’s also unclear on the extent that semiconductor materials and manufacturing equipment used to manufacture chips would fall under the tariffs. 

Bernstein's Stacy Rasgon on semiconductor tariffs, impact on sector and AMD Q2 results

Complex supply chains 

Potential tariff strategies could also be complicated by the intricate and interdependent nature of the semiconductor supply chain. 

Rasgon gave the example of American chip designer Qualcomm, which sends their designs to TSMC to be manufactured in Taiwan and then imported to the U.S. 

“Does that mean those [chip imports] would not be tariffed, because they’re made at TSMC, and TSMC is building in the U.S.?… I don’t know. Hopefully that’s how it would be,” he said. 

Another large buyer of semiconductors in the U.S. are cloud service providers like Amazon Web Services and Google, which are essential to power Washington’s AI plans. 

According to a recent report from ITIF, semiconductors contribute $7 trillion in global economic activity annually by underpinning a range of downstream applications including AI and “big data.”

In a potential sign of American companies seeking to move their chip supply chains into the U.S., Apple CEO Tim Cook, alongside Trump at the White house Wednesday, announced that it will be supplied chips from Samsung’s production plant in Texas. 

The company also announced an additional $100 billion in U.S. investments, raising its total investment commitments in the country to $600 billion over the next four years.

Continue Reading

Technology

SoftBank Vision Fund posts $4.8 billion gain to drive second straight quarter of group profit

Published

on

By

SoftBank Vision Fund posts .8 billion gain to drive second straight quarter of group profit

Masayoshi Son, chairman and chief executive officer of SoftBank Group Corp., speaks at the SoftBank World event in Tokyo, Japan, on Wednesday, July 16, 2025.

Kiyoshi Ota | Bloomberg | Getty Images

SoftBank Group on Thursday reported fiscal first-quarter profit that topped expectations, driven by gains in its Vision Fund tech investment arm.

The Japanese giant reported 421.8 billion yen ($2.87 billion) in the quarter ended June, versus 127.6 billion yen expected, according to LSEG consensus estimates. It is the second straight quarter of profit for SoftBank. The company reported a 174.28 billion yen loss in the same period last year.

In the fiscal first quarter, SoftBank said the value of its Vision Funds rose $4.8 billion. Profit for the Vision Funds segment, which takes into account other factors like expenses, hit 451.4 billion yen in the quarter, versus a loss in the same period last year.

SoftBank has been on spending spree related to AI. The Japanese giant is leading a $40 billion funding round into ChatGPT developer OpenAI and it is currently waiting for its $6.5 proposed acquisition of AI chip firm Ampere Computing to close.

The Vision Fund performance will be welcomed by investors hoping to see those big AI bets start to pay off.

SoftBank said that the rise of the value of the Vision Fund was helped by gains at public companies such as ride-hailing firm Grab, as well as Indian food delivery firm Swiggy. The performance was also aided by private investments in some of firms in India in which the fund has a position.

Meanwhile, SoftBank is a key company in the massive $500 billion Stargate project in the U.S. that aims to build data centers and AI infrastructure in the country. Investors are waiting for details on how SoftBank plans to fund this spending.

In May, SoftBank posted its first annual profit in four years for the fiscal year ended March, helped by gains in SoftBank’s older investments in AlibabaT-Mobile and Deutsche Telekom.

In the June quarter, SoftBank reported a 256.55 billion yen investment loss for its other holdings, which weighed on the group’s overall profit. The Japanese firm said it posted an investment loss on the sale of shares of T-Mobile and Alibaba, which was partially offset by a gain on shares of semiconductor giant Nvidia.

SoftBank said on Thursday that it sold 13 million shares of T-Mobile in August for $3 billion.

Meanwhile Arm, the chip designer that is majority-owned by SoftBank, contributed a 8.66 billion yen loss to the Japanese company. SoftBank attributed this to increase research and development expenses, which led to investments growing faster than revenues.

Continue Reading

Technology

Firefly Aerospace prices shares at $45, above the expected range

Published

on

By

Firefly Aerospace prices shares at , above the expected range

The Blue Ghost Mission Operations Engineer, Jaxon Liebeck, showcases the Blue Ghost moon lander at Firefly Aerospace headquarters on Tuesday, Dec. 3, 2024 in Cedar Park.

Houston Chronicle/hearst Newspapers | Hearst Newspapers | Getty Images

Firefly Aerospace priced shares in its IPO at $45 on Wednesday, above its expected range.

The Texas-based rocket maker will debut on the Nasdaq Thursday under the ticker symbol “FLY.” The offering raised $868 million and values the company at about $6.3 billion.

Firefly filed its initial prospectus in July and upped its IPO range this week to $41 to $43 a share, from an initial range of $35 to $39.

The space technology sector has seen rising investor interest over the last few years as billionaire investors such as Elon Musk and Jeff Bezos put their money behind SpaceX and Blue Origin, respectively.

So far this year, space technology companies Voyager Technology and Karman Holdings have gone public.

The broader IPO landscape has also seen major public debuts this year from Figma, CoreWeave and Circle as the market for public offerings reopens following a prolonged drought.

Read more CNBC tech news

Volunteers experience life on Mars in the Utah desert

Continue Reading

Trending